Researchers working on an incurable blood cancer can now use a new lab model which could make testing potential new ...

Regeneron Pharmaceuticals has won FDA accelerated approval of its Lynozyfic treatment for certain patients with the blood ...

Free-floating DNA carrying cancerous mutations was detected in blood three years before any other signs of cancer appeared.

The U.S. Food and Drug Administration has approved Regeneron's cancer therapy, the company said on Wednesday, providing ...

For years, scientists have been trying to figure out how to apply a last-line blood cancer treatment to solid tumours. New ...

A 2022 study claims to have found that a certain blood type is linked to a higher risk of colorectal cancer. Colorectal ...

A routine blood test may be able to detect cancer more than three years before diagnosis, a new study suggests. In the study, ...

While the American Cancer Society does not recommend “routine” prostate-specific antigen screening for men, there's a lot to ...

New research from UC Davis Comprehensive Cancer Center has uncovered an evolutionary change that may explain why certain ...

To develop the test, researchers analyzed 6553 blood samples, 3076 from patients with cancer and 3477 from healthy ...